The Veterinary Medicine Market is growing owing to the increasing prevalence of zoonotic and chronic animal diseases, increasing pet ownerships and increasing awareness of animal health and welfare. With the increasing focus on the care of companion animals and the expansion of livestock production to meet the global demand for food, the need for advanced veterinary medicines, vaccines, diagnostics and preventive health care solutions continues to grow. Biotechnology, digital diagnostics, telemedicine, wearable animal health monitoring devices and precision medicine are all advancing and changing the veterinary practice landscape, leading to earlier disease detection and improved treatment outcomes in both the companion animal and livestock segments.
The global Veterinary Medicine Market is valued at USD 52.91 Billion in 2025 and is projected to reach USD 115.40 Billion by 2035, at a CAGR of 8.11% during the forecast period 2026-2035. The growth is driven by increasing expenditure on pet healthcare, growing need for livestock health management, rising adoption of preventive healthcare practices and advancements in veterinary pharmaceuticals and biologics. Also, the rapid growth of online veterinary pharmacies, new systems for delivering drugs, and greater investments in research on animal health are creating new opportunities for growth in developed and emerging economies.
Veterinary Medicine Market
Key Players:
Some of the major companies operating in the Veterinary Medicine Market are Zoetis Inc., Merck Animal Health, Boehringer Ingelheim Animal Health, Elanco Animal Health Inc., Ceva Santé Animale, Virbac S.A., Dechra Pharmaceuticals PLC, IDEXX Laboratories, Inc., Phibro Animal Health Corporation, Vetoquinol S.A., Neogen Corporation, and others.
Strategic Developments & Industry Innovations:
- In December 2024, Zoetis announced the global launch of Vetscan OptiCell™, a cartridge-based hematology analyzer that utilizes artificial intelligence and advanced viscoelastic focusing technology to enhance in-clinic veterinary diagnostics.
- In February 2025, Merck Animal Health completed the acquisition of Elanco Animal Health's aquaculture business, strengthening its portfolio with fish vaccines, anti-parasitic solutions, and aquaculture nutrition products.
- Veterinary healthcare providers are increasingly integrating telemedicine platforms, AI-powered diagnostics, and wearable health monitoring technologies to improve disease detection, treatment efficiency, and animal wellness management.
- Growth in e-commerce and online veterinary pharmacies is improving access to veterinary medicines and preventive healthcare products, particularly in emerging markets and remote regions.
Top Players Driving Innovation in the Veterinary Medicine Market:
1. Zoetis Inc.: Leading Innovation in Animal Health Solutions
Zoetis is the world’s largest dedicated animal health company and a leading innovator of medicines, vaccines, diagnostics and digital health solutions. The company provides a broad portfolio of pharmaceuticals, biologics and diagnostic technologies to both the companion animal and livestock sectors.
Zoetis is a global leader in animal health with a focus on preventive healthcare, precision diagnostics and digital veterinary solutions. The company’s ongoing investments in research and development, together with its broad international footprint, allow it to respond to changing animal health requirements and to improve productivity and welfare outcomes.
2. Merck Animal Health: Advancing Preventive Care and Veterinary Innovation
Merck Animal Health is now a leading global player in the veterinary medicines market, providing a comprehensive portfolio of vaccines, pharmaceuticals, diagnostics, and animal monitoring tools. It places a high value on disease prevention, thus increasing productivity in livestock and pet healthcare.
Merck Animal Health strengthens its position in the market through strategic acquisitions, development of advanced biologics and investments in digital animal health technologies. Its increasing foothold in the livestock, aquaculture and companion animal segments, is driving holistic healthcare solutions worldwide.
3. Elanco Animal Health: Driving Accessible and Effective Veterinary Care
Elanco Animal Health remains a global leader in veterinary medicines and animal health products. The company is focused on pharmaceuticals, parasiticides, vaccines and novel treatment solutions that improve animal health and productivity.
Market growth has been aided heavily by the company’s development of convenient treatment options like oral care medications and focus on preventive healthcare. Elanco remains committed to investing in research, innovation and global expansion initiatives to improve animal welfare and access to healthcare.
How the Veterinary Medicine Market Is Transforming Animal Healthcare?
The veterinary medicine market is expected to observe significant growth due to the growing pet ownership, increasing livestock production and awareness about animal health across the globe. Biotechnology innovations, recombinant vaccines, precision medicine, artificial intelligence-enabled diagnostics, telemedicine and wearable health tracking devices are transforming veterinary medicine.
Zoetis, Merck Animal Health and Elanco Animal Health are leading the way in innovation with next generation therapeutics, preventive health solutions and digital veterinary technologies. Over the next decade, the veterinary medicine market will have an increasing role to play in supporting animal welfare, food security and global public health, with growing demand for companion animal care, livestock health management and affordable veterinary services.
